A Clinical Study of Kopuranthangi Chooranam in the Management of Thandagavatham (Lumbar Spondylosis) Among Patients Attending OPD, GSMC, Palayamkottai

Abstract

Lumbar spondylosis is a degenerative spinal condition that causes severe pain, stiffness, and functional disability. It has a major impact on daily activities of affected individual. Conventional management usually focus on relieving symptoms, but they provide temporary benefits and are associated with adverse reaction. Certain Siddha formulations offer a potential alternative due to their anti-inflammatory and rejuvenating properties. Objective: To evaluate the efficacy of Kopuranthangi chooranam in the management of Thandagavatham (lumbar spondylosis) among patients attending OPD in GSMC, Palayamkottai. Methods: A prospective, open-label, single arm clinical study was conducted among 20 patients diagnosed with lumbar spondylosis (Thandagavatham) based on clinical and radiological findings. Kopurathangi Chooranam (2 grams) was administered twice daily with ghee as Anubanam for 45 days. Outcome measures included Pain likert scale, Oswestry Disability Index (ODI), and range of spinal movements. Statistical analysis was performed using paired t- test, with p<0.05 considered significant. Results: The mean pain score significantly reduced from 4.85±1.03 to 1.45±0.51(p<0.001). The mean ODI score improved from 60.6±9.29 to 47.1±8.39 (p<0.001), indicating a significant reduction in functional disability. Progressive improvement was observed throughout the treatment period. No adverse effects were reported. Conclusion: Kopurathangi Chooranam demonstrated significant clinical efficacy in reducing pain and improving functional ability in patients with Thandagavatham (lumbar spondylosis). Further, large-scale randomized controlled trials are needed to validate these findings.